Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Oncoclínicas Group generated record earnings in the second quarter of 2023, R$309 million and a net profit of R$35 million 2023-08-16 19:00
Record number of participants expected at Medlab Asia & Asia Health 2023 2023-08-16 16:08
Nippon Express (Ireland) Opens New Warehouse in Dublin, Beginning Operations July 1 2023-08-16 14:00
Daewoong Pharmaceutical Initiates Global Export of 'Novel Drug' Launching 'Fexuprazan' in the Philippines 2023-08-16 13:00
MGI Unveils Latest MGISP-NEX and MGIFLP-L50 Automation Systems at Medlab Asia & Asia Health 2023 2023-08-16 11:00
Charmacy Pharmaceutical Has Obtained the Provincial Capital Support 2023-08-16 09:00
MedAlliance announces the completion of enrollment in SAVE Trial with SELUTION SLR for Treatment of AV Fistulas in Renal Dialysis Patients 2023-08-16 08:00
Transcenta to Present Three Study Results at ESMO 2023 2023-08-16 08:00
YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024 2023-08-16 05:00
CStone Pharmaceuticals Reports 2023 Interim Results and Updates 2023-08-15 22:33
Everest Medicines' Partner Venatorx Receives FDA Acceptance and Priority Review of New Drug Application for Cefepime-Taniborbactam to Treat Complicated Urinary Tract Infections (cUTI) 2023-08-15 20:19
Leading Asia Pacific Biopharmas Power Digital Engagement with Veeva CRM 2023-08-15 09:00
TB Alliance Announces Partnership with Remington Pharmaceuticals to Commercialize New Therapy for Drug-Resistant Forms of TB in Pakistan 2023-08-14 21:30
UMP Introduces Artificial Intelligence Technology for Enhanced Chest X-Ray Analysis Efficiency 2023-08-14 15:45
Kelun-Biotech announces that a Phase III clinical trial of core product SKB264 (MK-2870, TROP2-ADC) in patients with unresectable locally advanced, recurrent or metastatic TNBC who have failed second-line or above prior standard of care has met its primary endpoint 2023-08-14 12:50
Streamlining Generic Drug Immunogenicity Evaluation: EpiVax's "PANDA" Approach 2023-08-11 21:14
Move Aside Anti-Ageing, It's Age Reversal We're Talking Now 2023-08-11 13:49
First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients 2023-08-11 11:14
Antengene Enters into Commercialization Partnership with Hansoh Pharma for First/Only-in-Class XPO1 Inhibitor XPOVIO®(selinexor) in the Mainland of China 2023-08-11 08:00
First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients 2023-08-11 07:18
1 91 92 93 94 95 531